The critical concentration of C1-esterase inhibitor (C1-INH) in human serum preventing auto-activation of the first component of complement (C1)
- PMID: 15781109
- DOI: 10.1016/j.molimm.2004.09.025
The critical concentration of C1-esterase inhibitor (C1-INH) in human serum preventing auto-activation of the first component of complement (C1)
Abstract
C1-esterase inhibitor (C1-INH) was depleted from normal human serum (NHS) at 4 degrees C by affinity chromatography with a monoclonal anti-C1-INH antibody (mAb 13 E1) coupled to CNBr-activated Sepharose 4B. The C1-INH-depleted serum (C1-INH-depl-HS) had normal levels of C1, C4, and CH 50 and C1-INH concentration was less than 10% of normal (15 microg/ml in C1-INH-depl-HS compared to 230 microg/ml in NHS). C1-auto-activation in C1-INH-depl-HS was followed by measuring C4-consumption in a haemolytic assay and by detection of activated C1s in a C1s-ELISA. After a lag phase of 10-20 min, C1-auto-activation in C1-INH depl-HS occurred and reached its maximum after 40 min at 37 degrees C. In contrast, neutralization of C1-INH activity in NHS by addition of monoclonal antibodies directed against its C1s-binding site, resulted in an immediate, spontaneous C1-activation without a lag-phase and reached its maximum already after 20 min (mAb 140) and 25 min (mAb 88G2). Addition of highly purified C1-INH or NHS as source of C1-INH to C1-INH-depleted serum to a final concentration of 55 microg/ml (22% of normal C1-INH concentration in HS) was sufficient to control spontaneous C1-activation.
Similar articles
-
Activation of the first component of human complement, C1, by monoclonal antibodies directed against different domains of subcomponent C1q.J Immunol. 1986 Jul 1;137(1):255-62. J Immunol. 1986. PMID: 3486914
-
A mechanism for the spontaneous activation of the first component of complement, C1, and its regulation by C1-inhibitor.J Immunol. 1988 Dec 1;141(11):3930-6. J Immunol. 1988. PMID: 3183385
-
Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition.J Immunol. 1986 May 1;136(9):3378-83. J Immunol. 1986. PMID: 3485688
-
Structure and function of C1 inhibitor.Behring Inst Mitt. 1989 Jul;(84):142-50. Behring Inst Mitt. 1989. PMID: 2679529 Review.
-
The acquired C1-INH deficiencies with autoantibodies (AAE type II).Behring Inst Mitt. 1989 Jul;(84):165-72. Behring Inst Mitt. 1989. PMID: 2679532 Review.
Cited by
-
The relationship between brachial ankle pulse wave velocity and complement 1 inhibitor.J Korean Med Sci. 2009 Oct;24(5):831-6. doi: 10.3346/jkms.2009.24.5.831. Epub 2009 Sep 23. J Korean Med Sci. 2009. PMID: 19794979 Free PMC article. Clinical Trial.
-
C1q binding to surface-bound IgG is stabilized by C1r2s2 proteases.Proc Natl Acad Sci U S A. 2021 Jun 29;118(26):e2102787118. doi: 10.1073/pnas.2102787118. Proc Natl Acad Sci U S A. 2021. PMID: 34155115 Free PMC article.
-
More than a Pore: Nonlytic Antimicrobial Functions of Complement and Bacterial Strategies for Evasion.Microbiol Mol Biol Rev. 2021 Jan 27;85(1):e00177-20. doi: 10.1128/MMBR.00177-20. Print 2021 Feb 17. Microbiol Mol Biol Rev. 2021. PMID: 33504655 Free PMC article. Review.
-
Complement Activation in the Central Nervous System: A Biophysical Model for Immune Dysregulation in the Disease State.Front Mol Neurosci. 2021 Mar 4;14:620090. doi: 10.3389/fnmol.2021.620090. eCollection 2021. Front Mol Neurosci. 2021. PMID: 33746710 Free PMC article.
-
SERPING1 Variants and C1-INH Biological Function: A Close Relationship With C1-INH-HAE.Front Allergy. 2022 Mar 31;3:835503. doi: 10.3389/falgy.2022.835503. eCollection 2022. Front Allergy. 2022. PMID: 35958943 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous